"Cash position remains strong with a balance of $37.9 million as at 31 December 2023. Net operating cash outflows for the December quarter were $14.4 million. In addition, the company’s RDTI, which is due shortly, is expected to provide in excess of a further ~$10 million in cash funding. This funding will provide cash runway into late 2024."
So not far short of $50m still, they really do run efficiently when you consider all the trials they have running.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$8.65 |
Change
-0.050(0.57%) |
Mkt cap ! $2.734B | |||
| Open | High | Low | Value | Volume |
| $8.65 | $8.79 | $8.40 | $14.40M | 1.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59 | $8.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.65 | 21036 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |